Abstract
Eradication of Helicobacter pylori with currently available antibacterial agents is unsatisfactory due to the risk of side-effects and the emergence of resistance. The organism rapidly dies in vitro in the presence of urea at pH 6. When incubated in citrate buffer (pH 6) plus urea (10 mM) the five minute survival was 26% compared with 96% without urea and the survival progressively decreased with increasing urea concentrations, being only 9% in 50 mM urea. The bactericidal effect depended on pH as the organism survived in citrate buffer (pH 7) plus urea (50 mM). The death of the organism at pH 6 in the presence of urea was prevented by the addition of the competitive urease inhibitor hydroxyurea. These findings indicate that destruction of the organism is mediated by its exceptionally high urease activity. Harnessing this enzyme to induce self-destruction could provide a new approach to eradicating this common infection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Biasco G., Miglioli M., Barbara L., Corinaldesi R., di Febo G. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet. 1989 Dec 9;2(8676):1403–1403. doi: 10.1016/s0140-6736(89)92021-7. [DOI] [PubMed] [Google Scholar]
- Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet. 1984 Jun 16;1(8390):1348–1349. [PubMed] [Google Scholar]
- Ferrero R. L., Hazell S. L., Lee A. The urease enzymes of Campylobacter pylori and a related bacterium. J Med Microbiol. 1988 Sep;27(1):33–40. doi: 10.1099/00222615-27-1-33. [DOI] [PubMed] [Google Scholar]
- Flejou J. F., Bahame P., Smith A. C., Stockbrugger R. W., Rode J., Price A. B. Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut. 1989 Jan;30(1):60–64. doi: 10.1136/gut.30.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghelani A. M., Hale S., Coleman H., Radziwonik H., Robertson C., Atkinson M. Lack of in vitro activity of omeprazole against Campylobacter pylori. J Clin Pathol. 1990 Feb;43(2):171–172. doi: 10.1136/jcp.43.2.171-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glupczynski Y., Burette A., De Koster E., Nyst J. F., Deltenre M., Cadranel S., Bourdeaux L., De Vos D. Metronidazole resistance in Helicobacter pylori. Lancet. 1990 Apr 21;335(8695):976–977. doi: 10.1016/0140-6736(90)91043-a. [DOI] [PubMed] [Google Scholar]
- Graham D. Y., Klein P. D., Opekun A. R., Boutton T. W., Evans D. J., Jr, Evans D. G., Alpert L. C., Michaletz P. A., Yoshimura H. H., Adam E. Epidemiology of Campylobacter pylori infection: ethnic considerations. Scand J Gastroenterol Suppl. 1988;142:9–13. [PubMed] [Google Scholar]
- Mainguet P., Delmée M., Debongnie J. C. Omeprazole, campylobacter pylori, and duodenal ulcer. Lancet. 1989 Aug 12;2(8659):389–390. doi: 10.1016/s0140-6736(89)90569-2. [DOI] [PubMed] [Google Scholar]
- Mobley H. L., Cortesia M. J., Rosenthal L. E., Jones B. D. Characterization of urease from Campylobacter pylori. J Clin Microbiol. 1988 May;26(5):831–836. doi: 10.1128/jcm.26.5.831-836.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Offerhaus G. J., Rieu P. N., Jansen J. B., Joosten H. J., Lamers C. B. Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut. 1989 Nov;30(11):1552–1557. doi: 10.1136/gut.30.11.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shousha S., Keen C., Parkins R. A. Gastric metaplasia and Campylobacter pylori infection of duodenum in patients with chronic renal failure. J Clin Pathol. 1989 Apr;42(4):348–351. doi: 10.1136/jcp.42.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tompkins D. S., West A. P. Campylobacter pylori, acid, and bile. J Clin Pathol. 1987 Nov;40(11):1387–1387. doi: 10.1136/jcp.40.11.1387-a. [DOI] [PMC free article] [PubMed] [Google Scholar]